PRDS

Pardes Biosciences, Inc. Common Stock
PRDS

Overview Fund Activity
Delisted

PRDS was delisted on the 30th of August, 2023.

Back to rankings

68 hedge funds and large institutions have $87.2M invested in Pardes Biosciences, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 12 closing their positions.

Holders
68
Holders Change
-1
Holders Change %
-1.45%
% of All Funds
1.18%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
11
Increased
23
Reduced
15
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$10.8M
2
TCM
2
Tang Capital Management
California
$925K
3
BlackRock
3
BlackRock
New York
$3.47M
4
BCM
4
Bridgeway Capital Management
Texas
$393K
5
LCM
5
Lynx1 Capital Management
Puerto Rico
$4.21M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$1.4M
2
SCM
2
Sio Capital Management
New York
$0
3
PHS
3
PFM Health Sciences
California
$528K
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$0
5
IC
5
Ikarian Capital
Texas
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Wells Fargo
76
Wells Fargo
California
$0 152 -356 -70%
CFGS
77
Concourse Financial Group Securities
Alabama
– – – –
EI
78
Ellevest Inc
New York
$0 19 +19 New
SOW
79
State of Wyoming
Wyoming
$0 50 +50 New
CAL
80
Capital Advisors Ltd
Ohio
$0 151 +151 New
CS
81
Credit Suisse
Switzerland
$0 189 +175 +1,250%
1 2 3
4